{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:53:59Z","timestamp":1790790839412,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Changi Airport Group"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We aimed to test the sensitivity of naso-oropharyngeal saliva and self-administered nasal (SN) swab compared to nasopharyngeal (NP) swab for COVID-19 testing in a large cohort of migrant workers in Singapore. We also tested the utility of next-generation sequencing (NGS) for diagnosis of COVID-19. Saliva, NP and SN swabs were collected from subjects who presented with acute respiratory infection, their asymptomatic roommates, and prior confirmed cases who were undergoing isolation at a community care facility in June 2020. All samples were tested using RT-PCR. SARS-CoV-2 amplicon-based NGS with phylogenetic analysis was done for 30 samples. We recruited 200 subjects, of which 91 and 46 were tested twice and thrice respectively. In total, 62.0%, 44.5%, and 37.7% of saliva, NP and SN samples were positive. Cycle threshold (Ct) values were lower during the earlier period of infection across all sample types. The percentage of test-positive saliva was higher than NP and SN swabs. We found a strong correlation between viral genome coverage by NGS and Ct values for SARS-CoV-2. Phylogenetic analyses revealed Clade O and lineage B.6 known to be circulating in Singapore. We found saliva to be a sensitive and viable sample for COVID-19 diagnosis.<\/jats:p>","DOI":"10.1038\/s41598-021-82787-z","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T06:08:10Z","timestamp":1612418890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0569-3518","authenticated-orcid":false,"given":"Alvin Kuo Jing","family":"Teo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukti","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4951-0354","authenticated-orcid":false,"given":"Iain Beehuat","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Yin","family":"Cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Hao","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi Yi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel Tim Ee","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette Lin Ean","family":"Oon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Han","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian Sing","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Yang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"82787_CR1","unstructured":"World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report (2020). https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/20200121-sitrep-1-2019-ncov.pdf. Accessed 1 September 2020."},{"key":"82787_CR2","unstructured":"Worldometer. COVID-19 Coronavirus Pandemic (2020). https:\/\/www.worldometers.info\/coronavirus\/#countries. Accessed 1 September 2020."},{"key":"82787_CR3","unstructured":"Ministry of Health Singapore. COVID-19 Situation Report (2020). https:\/\/covidsitrep.moh.gov.sg\/. Accessed 1 September 2020."},{"key":"82787_CR4","doi-asserted-by":"publisher","first-page":"101869","DOI":"10.1016\/j.tmaid.2020.101869","volume":"37","author":"Priyanka","year":"2020","unstructured":"Priyanka, Choudhary, O. P., Singh, I. & Patra, G. Aerosol transmission of SARS-CoV-2: The unresolved paradox. Travel Med. Infect. Dis. 37, 101869 (2020).","journal-title":"Travel Med. Infect. Dis."},{"key":"82787_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.3204","author":"BE Young","year":"2020","unstructured":"Young, B. E. et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA. https:\/\/doi.org\/10.1001\/jama.2020.3204 (2020).","journal-title":"JAMA"},{"key":"82787_CR6","unstructured":"Centers for Disease Control and Prevention. Information for Laboratories about Coronavirus (COVID-19). In Centers for Disease Control and Prevention (2020). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/guidelines-clinical-specimens.html. Accessed 15 July 2020."},{"key":"82787_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","volume":"20","author":"KK-W To","year":"2020","unstructured":"To, K.K.-W. et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study. Lancet. Infect. Dis 20, 565\u2013574 (2020).","journal-title":"Lancet. Infect. Dis"},{"key":"82787_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.262","author":"EC Leung","year":"2020","unstructured":"Leung, E. C., Chow, V. C., Lee, M. K. & Lai, R. W. Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.262 (2020).","journal-title":"J. Med. Virol."},{"key":"82787_CR9","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1093\/cid\/ciaa797","volume":"71","author":"SCY Wong","year":"2020","unstructured":"Wong, S. C. Y. et al. Posterior oropharyngeal saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin. Infect. Dis. 71, 2939. https:\/\/doi.org\/10.1093\/cid\/ciaa797 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"82787_CR10","doi-asserted-by":"publisher","first-page":"m1443","DOI":"10.1136\/bmj.m1443","volume":"369","author":"S Zheng","year":"2020","unstructured":"Zheng, S. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January\u2013March 2020: Retrospective cohort study. BMJ 369, m1443 (2020).","journal-title":"BMJ"},{"key":"82787_CR11","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.jinf.2020.04.005","volume":"81","author":"L Azzi","year":"2020","unstructured":"Azzi, L. et al. Saliva is a reliable tool to detect SARS-CoV-2. J. Infect. 81, e45\u2013e50 (2020).","journal-title":"J. Infect."},{"key":"82787_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00776-20","author":"E Williams","year":"2020","unstructured":"Williams, E., Bond, K., Zhang, B., Putland, M. & Williamson, D. A. Saliva as a noninvasive specimen for detection of SARS-CoV-2. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/JCM.00776-20 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"82787_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.16.20067835","author":"AL Wyllie","year":"2020","unstructured":"Wyllie, A. L. et al. Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. MedRXiV. https:\/\/doi.org\/10.1101\/2020.04.16.20067835 (2020).","journal-title":"MedRXiV."},{"key":"82787_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa848","author":"AJ Jamal","year":"2020","unstructured":"Jamal, A. J. et al. Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa848 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"82787_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01438-20","author":"M Nagura-Ikeda","year":"2020","unstructured":"Nagura-Ikeda, M. et al. Clinical evaluation of self-collected saliva by RT-qPCR, direct RT-qPCR, RT-LAMP, and a rapid antigen test to diagnose COVID-19. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/JCM.01438-20 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"82787_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00465","author":"LM Czumbel","year":"2020","unstructured":"Czumbel, L. M. et al. Saliva as a candidate for COVID-19 diagnostic testing: A meta-analysis. Front. Med. https:\/\/doi.org\/10.3389\/fmed.2020.00465 (2020).","journal-title":"Front. Med."},{"key":"82787_CR17","unstructured":"Singapore Statutes Online, Government of Singapore. Infectious Diseases Act. Chapter 137 (1977)."},{"key":"82787_CR18","unstructured":"Centers for Disease Control and Prevention. Research use only 2019-novel coronavirus (2019-nCoV) real-time RT-PCR primers and probes. In Centers for Disease Control and Prevention (2020). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/lab\/rt-pcr-panel-primer-probes.html. Accessed 15 July 2020."},{"key":"82787_CR19","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1093\/molbev\/msz053","volume":"36","author":"AX Han","year":"2019","unstructured":"Han, A. X., Parker, E., Scholer, F., Maurer-Stroh, S. & Russell, C. A. Phylogenetic clustering by linear integer programming (PhyCLIP). Mol. Biol. Evol. 36, 1580\u20131595 (2019).","journal-title":"Mol. Biol. Evol."},{"key":"82787_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0770-5","author":"A Rambaut","year":"2020","unstructured":"Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. https:\/\/doi.org\/10.1038\/s41564-020-0770-5 (2020).","journal-title":"Nat. Microbiol."},{"key":"82787_CR21","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.25.061499","author":"BGS Hilaire","year":"2020","unstructured":"Hilaire, B. G. S. et al. A rapid, low cost, and highly sensitive SARS-CoV-2 diagnostic based on whole genome sequencing. BioRxiv. https:\/\/doi.org\/10.1101\/2020.04.25.061499 (2020).","journal-title":"BioRxiv."},{"key":"82787_CR22","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.10.242677","author":"RC Bhoyar","year":"2020","unstructured":"Bhoyar, R. C. et al. High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing. BioRxiv. https:\/\/doi.org\/10.1101\/2020.08.10.242677 (2020).","journal-title":"BioRxiv."}],"updated-by":[{"DOI":"10.1038\/s41598-021-89880-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82787-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82787-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T22:28:33Z","timestamp":1670020113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-82787-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["82787"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-82787-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"23 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-89880-3","URL":"https:\/\/doi.org\/10.1038\/s41598-021-89880-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yukti Choudhury, Chae Yin Cher, Zi Yi Wan, and Min Han Tan are employees of, and affiliated with, Lucence. Y.C. and M.H.T. are shareholders of Lucence; M.H.T. is a director of Lucence. An affiliated entity of Lucence is the applicant of certain patent applications for relevant diagnostics. Y.C., C.Y.C. and\/or M.H.T. are named inventors for some of these patent applications. At the time of this research, patents are pending for the next-generation sequencing approach (SG App. No. 10202007270P) and the saliva testing process (SG App. No. 10202007826S) discussed in the manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3134"}}